Literature DB >> 32364072

The Epigenetic Modification of Epigallocatechin Gallate (EGCG) on Cancer.

Linqi Yang1, Wenqi Zhang2, Saiyam Chopra2, Deeepjyot Kaur2, Huibing Wang1, Meng Li1, Pingping Chen1, Wei Zhang1.   

Abstract

Among the major components of green tea, epigallocatechin-3-gallate (EGCG) is the most effective for its anti-cancer characteristics. The bulk of studies provide the mechanisms of suppressive function of EGCG are involved in alteration of cancer cell cycle, development, and apoptosis through activation/inhibition of several signal pathways. Another mechanism that explains the multiple effects exerted by EGCG in cancer is the epigenetic change by DNA methylation or methyltransferases, histone acetylation or deacetylases, and no coding RNAs (micoRNAs). Furthermore, decontrolled expression of miRNA transcription has been tested to be directly regulated by oncogenic and tumor-suppressor transcription factors. Recently, several proteins have been identified as miRNA direct interactors by EGCG. However, the mechanisms explaining the action of miRNA being modulated by EGCG have not been completely understood yet. This review summarizes the state of epigenetic change being modulated by EGCG in a variety of cancers and oncogenic and tumor-suppressor transcription factors. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Epigallocatechin-gallate (EGCG); cancer; epigenetic regulators; methyltransferases; miRNA; micoRNA

Mesh:

Substances:

Year:  2020        PMID: 32364072     DOI: 10.2174/1389450121666200504080112

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  2 in total

1.  Combined effects of cigarette smoking, DNA methyltransferase 3B genetic polymorphism, and DNA damage on lung cancer.

Authors:  Chia-Chen Huang; Chung-Yu Lai; Chin-Hung Tsai; Jiun-Yao Wang; Ruey-Hong Wong
Journal:  BMC Cancer       Date:  2021-09-29       Impact factor: 4.638

2.  EGCG prevents pressure overload‑induced myocardial remodeling by downregulating overexpression of HDAC5 in mice.

Authors:  Xiao Han; Chang Peng; Lixin Huang; Xiaomei Luo; Qian Mao; Shuqi Wu; Huanting Zhang
Journal:  Int J Mol Med       Date:  2021-11-29       Impact factor: 4.101

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.